Sigma Lithium

Phase A — Understand the business

Lens 1 · Company Overview

Sigma Lithium Corporation is incorporated in Canada (Toronto registered office), operates entirely in Brazil, reports in USD under IFRS, and trades as SGML on Nasdaq . Auditor is **Grant Thornton Auditores Independentes, São Paulo** . Shares outstanding: 111,402,979 as of 2025-12-31 ; corroborated at 111.40M .

How it makes money: one revenue line — sale of lithium-oxide (spodumene) concentrate, grade nominally SC5.5, invoiced on Chinese SC6 CIF benchmarks with grade/price adjustments. Nameplate at Grota do Cirilo (Greentech Plant 1) is 270,000 t/yr of concentrate (~38–40kt LCE) . FY2025 revenue **US$110.01M** (down from US$151.35M in 2024) .

Customers/counterparties: historically Glencore (multiple 22kt shipments 2023–24, 50% prepaid at a premium), Yahua, and — critically — Mitsui, which terminated its 2019 pre-agreement in Jan 2023 . In 2025 Sigma signed **US$146M of new offtake prepayments**: US$96M for 70,500t (2026 delivery) and US$50M for 40,000t/yr over three years . The commercial model has shifted from spot-to-Glencore toward prepayment-financed offtake — a tell that traditional working-capital debt is scarce.

Contract structure: no take-or-pay of note; pricing floats with the SC6 benchmark, so revenue is fully exposed to the lithium cycle. This is not a recurring-revenue or contracted-margin business — it is a commodity price-taker.

Commercial-layer files for critical-materials are all marked missing in the Step-0 context; Lens 1–4 are therefore web/filing-grounded, not KB-grounded.

Lens 2 · Supply Chain

Upstream inputs → Sigma → end customer, named:

• Deposit/inputs: self-mined pegmatite ore (Grota do Cirilo, Minas Gerais). Reserve 77.0 Mt @ 1.40% Li₂O (P&P), resource ~109 Mt @ 1.39%, ~25-year mine life at 520ktpa ``. Grade is genuinely high for hard rock — a real physical advantage. Reagents (dense-media/flotation) and diesel are the main consumables; DMS ("dry-stacking", low water) is the ESG pitch.
• Processing: Greentech Plant 1 (270ktpa, operating); Greentech Plant 2 under construction to reach 520ktpa ``.
• Logistics chokepoint: trucked ~500 km to the Port of Vitória (Espírito Santo) → shipped to China. Inland trucking + a single export port is the physical single point of failure.
• Mining contractor: work is contracted out — and Sigma abruptly switched mining contractors in late Oct 2025, demobilising the mine for "restructuring," which triggered the November crash ``. Contractor dependence is a live operational risk, not a theoretical one.
• Buyers (converters): Glencore (trading intermediary), Yahua (Chinese converter), plus the unnamed 2025 offtake counterparties. End demand = Chinese lithium-carbonate/hydroxide plants → cathode → EV/ESS batteries.

Chokepoints/single-source: (1) one mine, (2) one export port, (3) contractor-operated mining, (4) demand concentrated in Chinese converters. Four serial single points of failure — the supply chain is thin by design (it's one asset).

Lens 3 · Competitive Advantages (moats)

What's real:

• Grade + cost. Sigma reports CIF-China cash cost ~US$442–458/t in 2025 and an all-in sustaining cost of ~US$592/t on 2026 guidance ``. In hard-rock terms that is genuinely first/second-quartile — driven by the 1.4% grade. This is the one durable edge.
• Reserve scale + life. 25-year, 77Mt reserve is a large, long-life orebody — optionality most juniors lack.
• Jurisdiction/logistics. Brazil (vs. Australia/Africa) is closer to Atlantic markets and outside the China–Australia axis; a modest geopolitical-diversification premium.

What's marketing, not moat:

• "Triple/Quintuple Zero Green" branding. ESG positioning is a soft differentiator; spodumene is a fungible commodity priced on Li₂O content and impurities, not on carbon story. Converters pay for chemistry, not virtue. The green premium is real but thin and cyclical.
• Bargaining power is weak. A single-asset ~110ktLCE-scale producer selling into concentrated Chinese buying power has little pricing power; the shift to prepayment offtake is the buyers extracting terms.

Verdict on moat: the moat is a cost-curve position on one orebody, not a franchise. It protects margins at mid-cycle prices and evaporates at trough prices — which is exactly what 2024–25 demonstrated (a net loss despite "low cost"). Cost leadership among hard-rock peers, but no moat against the price.

Lens 4 · Segments

segments.csv is empty , so no research-layer segment grounding exists. Functionally there is **one product segment** (lithium concentrate) and **one geography** (Brazil production → China-weighted sales). A secondary line emerged in 4Q25/1Q26: **~650,000 tonnes of "high-purity lithium fines"** — a lower-value byproduct/tailings stream sold to clear inventory during the restructuring, alongside ~5,000t of premium concentrate . This is not a durable second segment; it's inventory monetisation.

Trend: revenue decelerated hard — US$151.35M (2024) → US$110.01M (2025), −27% `` — as realised prices collapsed faster than volumes grew. Then a sharp 1Q26 re-acceleration (revenue +150% QoQ to US$42.3M) on the price rebound. Segment mix tells you nothing here; the price is the whole story.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — Q1 2026)

The most recent print (Q1 2026, reported 2026-05-15) is the pivot the bull case rests on:

• Revenue: US$42.3M, +150% QoQ (vs. 4Q25), highest since 1Q25 (US$48M) ``.
• Net income: US$11.1M — a swing to profit ``.
• Margins (record): gross 61%, EBITDA 39%, net 26% ``.
• Volume: ~23,000t of concentrate sold ``.
• Realised price: US$1,790/t SC5 (≈US$2,150/t SC6) vs. US$630/t SC5 (US$756 SC6) in 3Q25 — a ~2.8x jump in realised price in two quarters ``. This is the entire beat: price, not operations.
• Debt: total debt US$134M, −21% YoY; trade-finance debt cut to US$19M . Cash rose to **~US$28M by 2026-05-15** from a razor-thin US$6.2M at 2025-12-31 ``.
• Market reaction: shares surged on the print ; the stock is up **+138% over the trailing 52 weeks** off the November low .

Flag vs. own history: the record margin is real but entirely price-driven and freshly recovered from a base of near-insolvency (US$6.2M cash in Dec-25, BofA flagging late vendor payments in Aug-25). One good quarter after a 29% two-day crash is a fragile foundation, not a trend.

Lens 6 · Earnings Calls (sentiment trend)

transcripts/ is empty ``; sentiment is web-derived and labelled.

Tonal arc across the last ~4 calls ``:

• 3Q24–4Q24: confident — "record production," "significant cost reductions," Investor-Day triple-capacity plan.
• 1Q25–2Q25: defensive but disciplined — "cost outperformance," "deleveraging," "on-target production." Management pivoted the narrative from growth to survival/cost as prices fell.
• 4Q25 (post-restructuring): damage-control — "successful restructuring," mine remobilised, "resilience achieved throughout the down cycle." The abrupt contractor change is framed as a fleet upgrade "to match Greentech 3.0."
• 1Q26: victory-lap — "record profitability," "highest margins in history."

Recurring phrases: "Green/Quintuple Zero," "lowest-cost quartile," "self-funded/low-capex expansion," "climate pioneer." Things they stopped saying: the 2023-era "strategic review / final round" M&A language, and the US$15.3B NPV feasibility headline (see Lens 10). Sentiment is high-beta to the lithium price — the tone is a coincident indicator, not a leading one.

Lens 7 · Comps

Multiples are `` with source/date, or n/a. Peers pulled from the lithium majors (index has no critical-materials peer set populated).

Read: SGML's EV/Sales 14.4x is extreme for a single-asset hard-rock producer — Pilbara (the cleanest comp) is a far larger, multi-asset spodumene pure-play at a ~$6B cap. On any normalised basis SGML trades at a scarcity/takeover premium, not a fundamentals multiple; the EBITDA multiple (585x) is meaningless on a trough-EBITDA denominator but signals the market is pricing forward recovery, not trailing reality. The honest comp is Pilbara — and SGML looks richly valued against it on an EV/resource-tonne and EV/Sales basis. (Precise per-tonne EV comps: n/a.)

Lens 8 · Stock-Price Catalysts (>5% moves, ~5-year pattern)

The tape reveals what the market actually reacts to for this name — and it is not quarterly operations:

• Feb 2023: Tesla takeover rumor (Bloomberg) — shares spiked; "Tesla weighing a bid" ``.
• Mar 2023: Grizzly Research short report — sharp drop; "bogus feasibility studies" ``.
• Nov 2023: "Strategic review advanced to a final round" — pop on deal hope ``; no deal ever closed — the single most important negative catalyst-that-wasn't.
• 2024: −64% for the year; 2025: −50%+ — the lithium-price collapse, the dominant multi-year force ``.
• Aug 2025: BofA flags vendor-payment delays / cash-flow stress ``.
• Late Oct–Nov 2025: abrupt mining-contractor switch → −29% in two sessions to ~$5.34 ``.
• Nov 2025: Paiva sells 56% of his holding at $9.84 ``.
• May 2026: Brazil waste-handling court ruling → −15% ``.
• Jun 9 2026: appeals court overturns the guarantee → +7% ``.
• May 2026: record Q1 print → surge; +138% trailing 52 weeks off the bottom ``.

Pattern: SGML trades on (1) M&A/takeover speculation, (2) the lithium price, (3) idiosyncratic Brazil/governance shocks — in that order of drama. Operations barely move it except when they signal distress. This is a headline/story stock, which is precisely why the valuation disconnects from trailing fundamentals.

---

Phase C — Judge people & books

Lens 9 · Management

• Ana Cristina Cabral-Gardner — Founder-CEO & Co-Chair. Ex-Goldman Sachs MD, Head of LatAm Capital Markets; co-founded A10 Investimentos (2012/2013) with Marcelo Paiva; A10 acquired 100% of Sigma in 2015 and took it from greenfield to producer ``. Track record: genuinely built a producing mine from scratch and got Phase 1 to steady-state — non-trivial. But she is a banker/capital-markets operator, not a mine builder by background; the promotional, ESG-forward, capital-markets-savvy style is a double-edged sword (see red flags).
• Marcelo Paiva — Co-Chair, A10 portfolio manager, controls the largest shareholder (A10 FIA). Sold 56% of his personal holding at US$9.84 in Nov 2025 — the largest insider sale in 12 months ``.
• Skin in the game: insiders collectively own only ~1.6% (~US$17M) ``. Despite the "founders acquired 100%" origin story, direct insider alignment today is thin, and the most senior insider was a net seller into the trough. (The A10 fund stake is larger, but it is external LPs' money, not personal founder capital.)
• Capital-allocation history: self-funded Phase 1; secured a BNDES BRL 487M, 16-year loan at 7.45% covering ~99% of Phase-2 capex `` — a genuinely good, cheap, long-dated financing win. Offset by the balance-sheet brinkmanship (US$6.2M cash at Dec-25, late vendor payments) and the disruptive contractor switch. Mixed: shrewd financier, operationally jumpy.
• Founder vs. professional: founder-controlled, promotion-heavy. Implies vision and deal-making energy, but weak minority-shareholder protection and a habit of managing the story as hard as the mine.

Lens 10 · Forensic Red Flags

financials.csv empty, so line-item forensics are web-grounded; labelled throughout.

• Cash flow vs. earnings: FCF −US$8.15M TTM against a −US$43.78M net loss and +US$2.58M EBITDA — EBITDA barely positive on a TTM basis means the "record margins" are a single-quarter, price-driven snapshot, not a run-rate. **Cash was near-critical (US$6.2M) at year-end 2025**.
• Vendor-payment stretching: BofA explicitly flagged increasing delays in vendor payments as a cash-flow-stress signal in Aug 2025 `` — a classic late-cycle liquidity tell. Watch payables/DPO in the exhibits (not on disk).
• Related-party structure: A10 (Paiva-controlled) provides administrative services to Sigma; CEO holds minority interests in related entities; transactions "reviewed by independent committees" ``. Founder-controlled + related-party service agreements + 1.6% insider float is a governance configuration that warrants scrutiny.
• Feasibility-study credibility: Grizzly's 2023 short alleged "bogus feasibility studies" and challenged the escalating NPV headlines (project NPV was marketed up to US$15.3B / 766ktpa in Jan 2023) ``. Sigma "vehemently denied" the report. No SEC enforcement resulted (see below), but the pattern of ever-larger resource/NPV headlines is a promotional flag to weigh.
• Reserve/resource inflation cadence: resource marketed 27% higher to 109Mt, reserve +40% to 77Mt, "world's 4th largest," "expected to reach 150Mt" . NI 43-101 (Canadian standard, explicitly **not comparable to SEC S-K 1300**, per the 40-F ) — a real, if standard-for-Canada, comparability caveat for US investors.
• Loss quality: net loss −US$50.19M FY2025 ; ROE **−49%** .

Regulatory findings (required sub-section):

• SEC Litigation Releases: None. `` (EDGAR EFTS LR, 2021–2026).
• SEC AAERs: None. ``.
• Non-SEC / other: the material live matter is the Brazil (Minas Gerais) environmental dispute — a lower court (May 2026) raised a possible US$10M financial guarantee over waste-handling at Grota do Cirilo affecting the towns of Araçuaí and Itinga; a Minas Gerais appeals court overturned it on 2026-06-09, instead requiring Sigma to fund independent environmental monitoring . There was also a **2023 Brazil mineral-rights dispute** that "cast a shadow" on the expansion . Environmental/permitting/mineral-title risk in Brazil is the standing legal overhang.
• Item 3 (Legal Proceedings): not captured — lives in AIF Exhibit 99.1, not on disk ``.
• Net: No US securities-enforcement history; the real forensic risks are liquidity brinkmanship, related-party governance, promotional resource/NPV marketing, and Brazilian environmental litigation — not accounting fraud on the record.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (base / bull / bear)

No forecast.ts create in --watchlist mode. EPS estimation is `` with arithmetic; the driver is the SC6 price × volume, and this is a swing-to-loss name, so the projection is scenario-dominated, not a smooth ramp.

Anchors: FY2025 revenue US$110M, net loss −US$50M ; Q1 2026 run-rate ~US$42M rev / US$11M NI at a ~US$2,150 SC6 realised price on ~23kt/quarter ; 2026 guided production 240,000t at AISC US$592/t ``; ~111.4M shares.

• Bear (SC6 ~$800, back toward the May-2026 spot): at ~$800 CIF against ~$592 AISC, cash margin is razor-thin; realised (SC5.5, lagged) can dip below all-in cost. Revenue ~US$140–170M, net loss/breakeven. FY2026E EPS ≈ −$0.20 to $0.00 ``.
• Base (SC6 ~$1,300–1,500 mid-cycle): 240kt at a blended ~$1,100–1,200 realised vs. $592 AISC → EBITDA ~US$120–150M, net income ~US$60–90M. FY2026E EPS ≈ $0.55–$0.80 . (Implies a forward P/E of ~15–22x at $12.37 — consistent with the "Forward P/E 8.11" figure if you use the more bullish street volume/price.)
• Bull (SC6 >$2,000 sustained + Phase 2 online): the Q1-2026 margin (61% GM) annualised on 240kt→ ramping 520kt is US$150M+ net income; FY2027E EPS > $1.50 with volume doubling ``. This is the case the current EV/Sales embeds.

The projection is a fan, not a line — the standard deviation of the lithium price swamps every operating variable. Base case ≈ $0.55–$0.80 FY2026 EPS, entirely contingent on price holding above ~$1,300 SC6.

Lens 12 · Bull vs Bear

Bull case. Highest-grade, lowest-cost hard-rock orebody in the Americas; AISC ~$592/t keeps it cash-generative through most of the cycle. BNDES cheap 16-yr financing de-risks the Phase-2 capacity doubling to 520kt (→125kt LCE by 2027) — volume growth plus a price recovery is a double-lever. 25-year reserve life. Brazil jurisdiction + green branding = a structural takeover target (Tesla looked once; the sector is consolidating — Rio bought Arcadium). Q1 2026 proved the asset prints ~26% net margins the instant price cooperates. Street is Strong-Buy, PT ~$18–20 ``.

Bear case (permanent-impairment risks).

1. Single-asset, single-commodity, price-taker — no diversification, no pricing power; one orebody + one port + contractor-operated mining. A prolonged sub-$800 SC6 environment (the 2024–25 reality) produces sustained losses and forces dilutive raises or distressed offtake terms.
2. Balance-sheet fragility — US$6.2M cash at Dec-25 and BofA-flagged vendor stretching show how close to the edge it ran. The recovery is one quarter old; a price relapse re-opens the liquidity hole.
3. Governance/promotional overhang — 1.6% insider float, Co-Chair dumping 56% into the trough, related-party admin agreements, a history of ever-escalating NPV headlines and a live Grizzly-style credibility question. Minority holders are along for the ride, not aligned with.

Pre-mortem (18 months out, thesis broke): SC6 stalled at ~$900; Phase-2 ramp slipped (contractor/permit/waste-monitoring friction in Minas Gerais); the offtake prepayments came due against under-priced volumes; cash tightened again and Sigma did an equity raise at a discount; the "takeover" never came because acquirers waited for a cheaper, cleaner entry. The stock round-trips to single digits.

Are multiples too high? Yes, on trailing reality — EV/Sales 14.4x and a net loss don't support $12.37 on fundamentals. The price is a forward-recovery + takeover option. If the option pays (price + M&A), it's cheap; if not, there is large downside to a Pilbara-style fundamentals multiple.

Contrarian view (what the market refuses to see): the market is treating Sigma as a quality growth compounder in recovery; it is more honestly a binary, leveraged call on the lithium price wrapped in an ESG-marketing layer, run by promoters with 1.6% skin in the game. The green branding is doing valuation work that a fungible commodity shouldn't support.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• Revenue concentration = the lithium price. 100% of the thesis is one exogenous commodity Sigma cannot influence. If SC6 disappoints 20–30% (entirely normal for lithium), base-case EPS goes from ~$0.65 to a loss — a ~$1.30 EPS swing on a $12 stock. Growth "disappointing by 20–30%" here isn't a haircut, it's a sign flip.
• The moat is weaker than bulls think. "Low cost" did not prevent a US$50M loss in 2025. Cost-quartile leadership is meaningless when the price sits below everyone's all-in cost. The green premium is a few dollars a tonne, not a franchise.
• Most dangerous competitor bulls underestimate: the brine majors (SQM, ALB in the Atacama at $3–5/kg) and Chinese lepidolite/African spodumene swing supply — they set the marginal price and can crush the spodumene curve. Sigma is a price-taker to their price-setting.
• Worst capital-allocation / incentive signals: Co-Chair sold 56% of his stake at $9.84 (Nov-25) — insiders monetising near the low; related-party A10 admin services; 1.6% insider ownership; a disruptive contractor switch that torched 29% of the market cap. That is not the behaviour of operators betting their own net worth on a coming boom.
• Assumptions that must hold for $12.37: SC6 sustained >$1,300; Phase-2 on time and on the BNDES budget; no further Minas Gerais waste/permit escalation; offtake prepayments not turning into under-priced delivery obligations; no dilutive raise. Several are outside management's control.
• The single scenario that permanently impairs: a multi-year sub-$900 SC6 trough (supply glut re-asserts) that forces distressed equity issuance or hands pricing to prepayment counterparties — permanent dilution/value transfer with no takeover bid to rescue it. Plausibility: moderate-to-high, given lithium already did exactly this in 2024–25.

Lens 14 · Management Questions (ordered by information value)

1. At what sustained SC6 CIF-China price does Sigma generate positive free cash flow after interest and sustaining capex — not just positive gross margin? Show the breakeven.
2. Walk through the liquidity bridge: with US$6.2M cash at year-end 2025 and BofA flagging vendor-payment delays, what is the minimum cash you will hold, and what covenant/repayment schedule (BNDES + offtake prepayments) must you clear in 2026–27?
3. Why did the Co-Chairman sell 56% of his holding in Nov 2025, and why is aggregate insider ownership only ~1.6% for a "founder-led" company?
4. Detail every related-party agreement with A10 (scope, fees, term, who signs on Sigma's side) and how the independent committee prices them at arm's length.
5. What exactly drove the October 2025 mining-contractor change — cost, performance, or dispute — and what is the new contractor's track record and rate structure?
6. On the offtake prepayments (US$96M/70.5kt and US$50M/40kt-3yr): what price mechanism governs delivery, and what is the downside if spot falls below the implied prepay price?
7. Phase-2 to 520kt: give the month-by-month ramp, the remaining capex vs. the BNDES BRL 487M, and the completion date you'll commit to publicly.
8. How do you respond, today, to Grizzly's 2023 feasibility-study allegations — and how should US investors reconcile NI 43-101 headlines (US$15.3B NPV, 150Mt) with SEC S-K 1300 economics?
9. What is the current status and worst-case exposure of the Minas Gerais waste-handling / environmental proceedings and the independent-monitoring obligation for Araçuaí and Itinga?
10. Is the company for sale? What happened in the 2023 "final-round" strategic review, and under what price would the Board transact now?
11. What is your realised-price discount to SC6 benchmark (grade, impurities, freight), quarter by quarter — the true price you capture vs. the headline?
12. What share of 2026–27 volume is contracted vs. spot, and at what floor/ceiling?
13. What is the plan if SC6 sits at $800 for eight consecutive quarters — and is an equity raise on the table?
14. What is the all-in sustaining cost trajectory as you double volume — economies of scale vs. deeper-pit strip-ratio and Brazilian cost inflation?
15. What capital-return framework (if any) applies once Phase 2 is funded, or is all cash flow reinvested/deleveraged indefinitely?

---